Mar. Drugs 2013, 11(4), 1336-1350; doi:10.3390/md11041336
Article

Immunomodulatory Effect of Marine Cembrane-Type Diterpenoids on Dendritic Cells

1 Department of Life Science and Institute of Biotechnology, National Dong Hwa University, Hualien 974, Taiwan 2 Graduate Institute of Marine Biotechnology, National Dong Hwa University, Pingtung 944, Taiwan 3 Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei 100, Taiwan
* Author to whom correspondence should be addressed.
Received: 26 February 2013; in revised form: 22 March 2013 / Accepted: 27 March 2013 / Published: 22 April 2013
(This article belongs to the Special Issue Marine Compounds and Inflammation)
PDF Full-text Download PDF Full-Text [382 KB, uploaded 22 April 2013 15:11 CEST]
Abstract: Dendritic cells (DCs) are antigen presenting cells, which can present antigens to T-cells and play an important role in linking innate and adaptive immunity. DC maturation can be induced by many stimuli, including pro-inflammatory cytokines and bacterial products, such as lipopolysaccharides (LPS). Here, we examined the immunomodulatory effects of marine cembrane compounds, (9E,13E)-5-acetoxy-6-hydroxy-9,13-dimethyl-3- methylene-3,3a,4,5,6,7,8,11,12,14a-decahydro-2H-cyclotrideca[b]furan-2-one (1), (9E,13E)- 5-acetoxy-6-acetyl-9,13-dimethyl-3-methylene-3,3a,4,5,6,7,8,11,12,14a-decahydro-2H-cyclotrideca[b]furan-2-one (2), lobocrassin B (3), (−)14-deoxycrassin (4), cembranolide B (5) and 13-acetoxysarcocrassolide (6) isolated from a soft coral, Lobophytum crassum, on mouse bone marrow-derived dendritic cells (BMDCs). The results revealed that cembrane-type diterpenoids, especially lobocrassin B, effectively inhibited LPS-induced BMDC activation by inhibiting the production of TNF-α. Pre-treatment of BMDCs with Lobocrassin B for 1 h is essential to prohibit the following activation induced by various toll-like receptor (TLR) agonists, such as LPS, zymosan, lipoteichoic acid (LTA) and Pam2CSK4. Inhibition of NF-κB nuclear translocation by lobocrassin B, which is a key transcription factor for cytokine production in TLR signaling, was evident as assayed by high-content image analysis. Lobocrassin B attenuated DC maturation and endocytosis as the expression levels of MHC class II and the co-stimulatory molecules were downregulated, which may affect the function of DCs to initiate the T-cell responses. Thus, lobocrassin B may have the potential in treatment of immune dysregulated diseases in the future.
Keywords: antigen presentation; bone-marrow derived dendritic cell (BMDC); marine natural compound; tumor necrosis factor-α

Supplementary Files

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Lin, C.-Y.; Lu, M.-C.; Su, J.-H.; Chu, C.-L.; Shiuan, D.; Weng, C.-F.; Sung, P.-J.; Huang, K.-J. Immunomodulatory Effect of Marine Cembrane-Type Diterpenoids on Dendritic Cells. Mar. Drugs 2013, 11, 1336-1350.

AMA Style

Lin C-Y, Lu M-C, Su J-H, Chu C-L, Shiuan D, Weng C-F, Sung P-J, Huang K-J. Immunomodulatory Effect of Marine Cembrane-Type Diterpenoids on Dendritic Cells. Marine Drugs. 2013; 11(4):1336-1350.

Chicago/Turabian Style

Lin, Ching-Yen; Lu, Mei-Chin; Su, Jui-Hsin; Chu, Ching-Liang; Shiuan, David; Weng, Ching-Feng; Sung, Ping-Jyun; Huang, Kao-Jean. 2013. "Immunomodulatory Effect of Marine Cembrane-Type Diterpenoids on Dendritic Cells." Mar. Drugs 11, no. 4: 1336-1350.

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert